Roxadustat for CKD-related Anemia in Non-dialysis Patients - ScienceDirect
Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta‐analysis - ScienceDirect
Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study - ScienceDirect
Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation | Arteriosclerosis, Thrombosis, and Vascular Biology
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement | Semantic Scholar
JCM | Free Full-Text | Current Status of Renal Anemia Pharmacotherapy—What Can We Offer Today
Frontiers | Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Frontiers | A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis - ScienceDirect
Cureus | Safety and Effectiveness of Roxadustat in Dialysis-Dependent Patients With Renal Anemia: A Hospital-Based Cohort Study | Article
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES) | SpringerLink
Frontiers | Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
PDF) Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies | springermedizin.de
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis | Aging
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
